Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Nicole Gonzales

Concepts (305)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cerebral Hemorrhage
27
2024
106
4.670
 Why?
Stroke
38
2024
1063
3.600
 Why?
Neurology
5
2024
103
2.370
 Why?
Tissue Plasminogen Activator
23
2024
219
2.250
 Why?
Brain Ischemia
18
2023
305
1.710
 Why?
Fibrinolytic Agents
17
2024
248
1.700
 Why?
Thrombolytic Therapy
14
2024
131
1.540
 Why?
Sexism
1
2024
55
0.860
 Why?
Hematoma
6
2015
54
0.830
 Why?
Ischemic Attack, Transient
1
2023
60
0.820
 Why?
Endarterectomy, Carotid
4
2015
47
0.760
 Why?
Platelet Aggregation Inhibitors
3
2022
439
0.710
 Why?
Education, Medical
1
2024
243
0.710
 Why?
Carotid Stenosis
4
2014
85
0.700
 Why?
Women
1
2020
52
0.680
 Why?
Decompressive Craniectomy
1
2019
6
0.660
 Why?
Time-to-Treatment
2
2021
178
0.620
 Why?
Medicine
1
2020
117
0.620
 Why?
Matrix Metalloproteinases
1
2019
89
0.600
 Why?
Stents
5
2015
504
0.590
 Why?
Mobile Health Units
3
2024
19
0.560
 Why?
Percutaneous Coronary Intervention
1
2022
466
0.550
 Why?
Angioplasty
2
2014
47
0.530
 Why?
Attention
1
2020
433
0.530
 Why?
Brain Injuries
1
2020
463
0.480
 Why?
Aged
39
2024
21892
0.470
 Why?
Emergency Medical Services
5
2024
518
0.470
 Why?
Cerebral Revascularization
1
2014
19
0.460
 Why?
Humans
68
2024
128019
0.440
 Why?
Treatment Outcome
28
2023
10110
0.440
 Why?
Middle Aged
41
2024
30812
0.430
 Why?
Diffusion Tensor Imaging
2
2024
73
0.420
 Why?
Cerebral Ventricles
3
2024
49
0.410
 Why?
Thiazolidinediones
2
2012
137
0.380
 Why?
Hypertension
3
2016
1234
0.380
 Why?
Female
46
2024
68016
0.350
 Why?
Male
48
2024
62757
0.350
 Why?
Health Education
4
2023
332
0.340
 Why?
Disability Evaluation
3
2021
285
0.320
 Why?
Prospective Studies
14
2024
7035
0.310
 Why?
Clinical Trials as Topic
6
2023
997
0.310
 Why?
Aged, 80 and over
19
2024
7029
0.300
 Why?
Schools
2
2007
436
0.260
 Why?
Awareness
1
2007
98
0.250
 Why?
Demyelinating Autoimmune Diseases, CNS
1
2005
3
0.250
 Why?
Paraneoplastic Syndromes, Nervous System
1
2005
12
0.250
 Why?
Encephalomyelitis, Acute Disseminated
1
2005
11
0.250
 Why?
Time Factors
11
2019
6479
0.240
 Why?
Anticoagulants
3
2019
615
0.240
 Why?
Risk Factors
9
2022
9696
0.240
 Why?
Cerebral Intraventricular Hemorrhage
1
2024
2
0.230
 Why?
Healthcare Disparities
2
2024
579
0.230
 Why?
Cerebral Blood Volume
1
2024
5
0.230
 Why?
American Heart Association
2
2023
296
0.210
 Why?
Skin Diseases, Vesiculobullous
1
2003
17
0.210
 Why?
Encephalitis, Herpes Simplex
1
2003
21
0.210
 Why?
Herpesvirus 2, Human
1
2003
28
0.210
 Why?
Pilot Projects
5
2023
1559
0.210
 Why?
Pyramidal Tracts
1
2023
26
0.210
 Why?
Hypoglycemic Agents
1
2012
1212
0.210
 Why?
Antihypertensive Agents
3
2016
481
0.210
 Why?
Postoperative Complications
1
2014
2456
0.210
 Why?
Cytochrome P-450 CYP2C19
1
2022
23
0.200
 Why?
Academic Medical Centers
2
2024
478
0.200
 Why?
Ambulances
2
2021
50
0.200
 Why?
Databases, Factual
3
2019
1264
0.190
 Why?
Heterozygote
1
2022
267
0.190
 Why?
PPAR gamma
3
2014
182
0.190
 Why?
Neuroprotective Agents
2
2015
109
0.190
 Why?
Adult
18
2024
35176
0.190
 Why?
Health Promotion
2
2007
716
0.190
 Why?
Faculty, Medical
1
2024
263
0.180
 Why?
Retrospective Studies
15
2019
14404
0.180
 Why?
Anxiety Disorders
1
2023
346
0.170
 Why?
United States
10
2024
13785
0.170
 Why?
Inpatients
1
2024
464
0.170
 Why?
Factor VIIa
2
2011
38
0.160
 Why?
Schools, Medical
1
2020
130
0.160
 Why?
Predictive Value of Tests
4
2019
1934
0.160
 Why?
Aspirin
1
2022
377
0.160
 Why?
Pipecolic Acids
2
2012
25
0.160
 Why?
Overweight
1
2023
522
0.160
 Why?
Recovery of Function
3
2019
630
0.160
 Why?
Prognosis
5
2024
3766
0.160
 Why?
Adenocarcinoma
1
2005
888
0.150
 Why?
Glasgow Coma Scale
1
2019
167
0.150
 Why?
Edema
1
2019
120
0.150
 Why?
Health Services Needs and Demand
1
2020
262
0.150
 Why?
Isoenzymes
1
2019
302
0.150
 Why?
Propensity Score
1
2019
264
0.150
 Why?
Communication
1
2024
838
0.150
 Why?
Disease Progression
3
2013
2598
0.150
 Why?
Dose-Response Relationship, Drug
4
2012
1943
0.140
 Why?
NF-E2-Related Factor 2
2
2015
67
0.140
 Why?
Mexican Americans
2
2009
113
0.140
 Why?
Genotype
1
2022
1828
0.140
 Why?
Sex Factors
3
2019
1942
0.140
 Why?
Hospital Mortality
2
2019
844
0.140
 Why?
Injury Severity Score
1
2019
509
0.130
 Why?
Platelet Transfusion
1
2017
59
0.130
 Why?
Anxiety
1
2023
951
0.130
 Why?
Decision Making
1
2023
846
0.130
 Why?
Ultrasonography, Doppler, Transcranial
3
2013
37
0.130
 Why?
Severity of Illness Index
8
2024
2703
0.130
 Why?
Tomography, X-Ray Computed
4
2021
2509
0.130
 Why?
Texas
4
2013
227
0.130
 Why?
Microglia
2
2008
228
0.120
 Why?
Fumarates
1
2015
9
0.120
 Why?
Quality of Health Care
1
2020
605
0.120
 Why?
Pneumonia, Viral
1
2020
337
0.120
 Why?
Coronavirus Infections
1
2020
333
0.120
 Why?
Anti-Inflammatory Agents
2
2011
467
0.120
 Why?
Antithrombins
2
2013
54
0.120
 Why?
Recombinant Proteins
4
2011
1286
0.120
 Why?
Retinoid X Receptors
1
2014
40
0.120
 Why?
Intraoperative Complications
1
2015
129
0.110
 Why?
Blood Pressure
3
2011
1711
0.110
 Why?
Perioperative Care
1
2015
149
0.110
 Why?
Cerebral Infarction
1
2014
42
0.110
 Why?
Cohort Studies
7
2022
5378
0.110
 Why?
Single-Blind Method
1
2014
267
0.110
 Why?
Neutrophil Infiltration
1
2014
103
0.110
 Why?
Follow-Up Studies
4
2017
4853
0.110
 Why?
Odds Ratio
3
2021
1018
0.100
 Why?
Quality Control
1
2013
156
0.100
 Why?
Delivery of Health Care
1
2020
888
0.100
 Why?
Genetic Predisposition to Disease
1
2021
2261
0.100
 Why?
Sulfonamides
3
2012
494
0.100
 Why?
Medical Records
1
2013
170
0.100
 Why?
Biomarkers
2
2019
3874
0.100
 Why?
Lung Neoplasms
1
2005
2327
0.100
 Why?
Telemedicine
2
2020
781
0.100
 Why?
Exercise
1
2023
1917
0.100
 Why?
Carotid Artery, Internal
1
2011
41
0.090
 Why?
Neurosurgical Procedures
1
2013
170
0.090
 Why?
Cyclooxygenase 2 Inhibitors
1
2011
21
0.090
 Why?
Celecoxib
1
2011
39
0.090
 Why?
Cerebral Amyloid Angiopathy
1
2011
9
0.090
 Why?
Collagen Type IV
1
2011
22
0.090
 Why?
Nervous System Diseases
1
2014
251
0.090
 Why?
History, 20th Century
1
2012
285
0.090
 Why?
Brain Edema
1
2011
60
0.090
 Why?
Carotid Arteries
1
2012
194
0.090
 Why?
NF-kappa B
1
2014
649
0.090
 Why?
Universities
1
2013
399
0.090
 Why?
Injections, Intra-Arterial
4
2013
24
0.090
 Why?
Nephrology
1
2011
60
0.090
 Why?
Risk Assessment
1
2019
3223
0.080
 Why?
Double-Blind Method
2
2012
1852
0.080
 Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2009
21
0.080
 Why?
Treatment Failure
2
2014
338
0.080
 Why?
Heparin
1
2011
246
0.080
 Why?
Resuscitation Orders
1
2009
46
0.080
 Why?
Research Design
2
2013
1034
0.080
 Why?
Venous Thrombosis
1
2011
161
0.080
 Why?
Health Care Surveys
1
2011
556
0.080
 Why?
Endovascular Procedures
1
2013
302
0.080
 Why?
Registries
2
2014
1873
0.080
 Why?
Hand Transplantation
1
2008
9
0.080
 Why?
Intracranial Thrombosis
1
2008
16
0.080
 Why?
Caffeine
1
2009
61
0.080
 Why?
Neutrophils
1
2014
1192
0.070
 Why?
Embolism
1
2008
41
0.070
 Why?
Hand Injuries
1
2008
36
0.070
 Why?
Hypothermia, Induced
1
2009
73
0.070
 Why?
Pyrazoles
1
2011
401
0.070
 Why?
Quality Improvement
1
2016
1093
0.070
 Why?
Surveys and Questionnaires
1
2020
5353
0.070
 Why?
Practice Patterns, Physicians'
2
2017
1260
0.070
 Why?
Renal Dialysis
1
2011
420
0.070
 Why?
Nerve Fibers, Myelinated
1
2005
43
0.060
 Why?
Adolescent
7
2014
20158
0.060
 Why?
Organ Transplantation
1
2008
218
0.060
 Why?
Kidney Failure, Chronic
1
2011
540
0.060
 Why?
Teaching
1
2007
210
0.060
 Why?
Methylprednisolone
1
2005
82
0.060
 Why?
Emergency Treatment
1
2006
113
0.060
 Why?
Emergency Service, Hospital
1
2016
1896
0.060
 Why?
Heart Diseases
1
2008
345
0.060
 Why?
Diffusion Magnetic Resonance Imaging
1
2005
96
0.060
 Why?
Brain Stem
1
2005
98
0.060
 Why?
Paralysis
1
2005
69
0.060
 Why?
Muscle Weakness
1
2005
83
0.060
 Why?
Phagocytosis
3
2014
361
0.060
 Why?
Injections, Intravenous
3
2011
197
0.060
 Why?
Fatal Outcome
1
2005
299
0.060
 Why?
Program Development
1
2007
357
0.060
 Why?
Quality-Adjusted Life Years
1
2024
106
0.060
 Why?
Administration, Intravenous
2
2017
137
0.060
 Why?
Case-Control Studies
3
2021
3324
0.060
 Why?
Ethanol
1
2009
585
0.060
 Why?
Peptides
1
2009
910
0.060
 Why?
Chi-Square Distribution
2
2017
511
0.050
 Why?
Hemorrhage
2
2023
643
0.050
 Why?
Meningitis, Aseptic
1
2003
13
0.050
 Why?
Growth and Development
1
2023
6
0.050
 Why?
Spinal Cord
1
2005
353
0.050
 Why?
Principal Component Analysis
1
2023
182
0.050
 Why?
Certification
1
2023
94
0.050
 Why?
Headache
1
2003
137
0.050
 Why?
Students
1
2007
570
0.050
 Why?
Catalase
2
2014
128
0.050
 Why?
Acute Disease
3
2011
961
0.050
 Why?
Brain
1
2014
2615
0.050
 Why?
Cost-Benefit Analysis
1
2024
567
0.050
 Why?
Respiratory Insufficiency
1
2005
311
0.050
 Why?
Partial Thromboplastin Time
2
2012
51
0.050
 Why?
Reperfusion
2
2013
36
0.050
 Why?
DNA, Viral
1
2003
348
0.050
 Why?
Macrophages
1
2008
1460
0.040
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
940
0.040
 Why?
Practice Guidelines as Topic
3
2017
1482
0.040
 Why?
Guideline Adherence
2
2017
523
0.040
 Why?
Hospital Bed Capacity
1
2020
24
0.040
 Why?
Caregivers
1
2007
810
0.040
 Why?
Health Care Rationing
1
2020
57
0.040
 Why?
Ethics, Medical
1
2020
78
0.040
 Why?
Kaplan-Meier Estimate
2
2012
851
0.040
 Why?
Magnetic Resonance Imaging
3
2023
3371
0.040
 Why?
Rats, Sprague-Dawley
2
2015
2258
0.040
 Why?
Young Adult
2
2014
12281
0.040
 Why?
Health Resources
1
2020
112
0.040
 Why?
Logistic Models
2
2017
1975
0.040
 Why?
Combined Modality Therapy
2
2013
1199
0.040
 Why?
Hospitals
1
2023
631
0.040
 Why?
CD36 Antigens
2
2008
35
0.040
 Why?
Arginine
2
2012
259
0.040
 Why?
Ventriculostomy
1
2017
22
0.040
 Why?
Autoantibodies
1
2005
1461
0.030
 Why?
Betacoronavirus
1
2020
247
0.030
 Why?
Drug Therapy, Combination
2
2012
1012
0.030
 Why?
Statistics, Nonparametric
1
2017
419
0.030
 Why?
Rats
2
2015
5199
0.030
 Why?
Disease Models, Animal
3
2014
3936
0.030
 Why?
Longitudinal Studies
1
2023
2706
0.030
 Why?
Dimethyl Fumarate
1
2015
11
0.030
 Why?
Thrombocytopenia
1
2017
184
0.030
 Why?
Body Mass Index
1
2023
2260
0.030
 Why?
Intensive Care Units
1
2020
734
0.030
 Why?
Neuroimmunomodulation
1
2014
67
0.030
 Why?
Biomedical Research
1
2020
632
0.030
 Why?
Perfusion Imaging
1
2014
56
0.030
 Why?
Animals
5
2015
34487
0.030
 Why?
Multivariate Analysis
1
2017
1492
0.030
 Why?
Sex Distribution
1
2014
356
0.030
 Why?
Health Services Accessibility
1
2020
895
0.030
 Why?
Tomography Scanners, X-Ray Computed
1
2012
19
0.030
 Why?
Erythrocytes
2
2008
673
0.020
 Why?
Cerebral Veins
1
2012
15
0.020
 Why?
Pandemics
1
2020
1473
0.020
 Why?
Quality of Life
1
2023
2672
0.020
 Why?
Cerebral Arteries
1
2012
57
0.020
 Why?
Plasminogen Activators
1
2011
7
0.020
 Why?
Mice, Inbred C57BL
2
2015
5268
0.020
 Why?
Heparin, Low-Molecular-Weight
1
2011
28
0.020
 Why?
Radiography
1
2013
794
0.020
 Why?
Obesity
1
2023
2859
0.020
 Why?
Magnetic Resonance Angiography
1
2012
235
0.020
 Why?
Analysis of Variance
1
2013
1266
0.020
 Why?
Length of Stay
1
2015
1114
0.020
 Why?
Mice
3
2015
16574
0.020
 Why?
Life Support Care
1
2009
29
0.020
 Why?
Buspirone
1
2009
4
0.020
 Why?
Meperidine
1
2009
4
0.020
 Why?
Shivering
1
2009
5
0.020
 Why?
Microcirculation
1
2009
137
0.020
 Why?
Adjuvants, Anesthesia
1
2009
9
0.020
 Why?
Microspheres
1
2009
125
0.020
 Why?
Brain Damage, Chronic
1
2008
20
0.020
 Why?
Anti-Anxiety Agents
1
2009
42
0.020
 Why?
Infusions, Intra-Arterial
1
2008
54
0.020
 Why?
Mice, Knockout
1
2015
2757
0.020
 Why?
Cerebral Angiography
1
2008
109
0.020
 Why?
Drug Combinations
1
2009
323
0.020
 Why?
Blood Flow Velocity
1
2009
404
0.020
 Why?
Behavior
1
2008
91
0.020
 Why?
Infusions, Intravenous
1
2008
390
0.020
 Why?
Enzyme Activators
1
2007
7
0.020
 Why?
Prostaglandin D2
1
2007
20
0.020
 Why?
Deep Brain Stimulation
1
2009
125
0.020
 Why?
Cultural Competency
1
2008
81
0.020
 Why?
Regression Analysis
1
2009
978
0.020
 Why?
Urokinase-Type Plasminogen Activator
1
2006
29
0.020
 Why?
Nitric Oxide Synthase Type II
1
2007
168
0.020
 Why?
Graft Survival
1
2008
503
0.020
 Why?
Reproducibility of Results
1
2013
3009
0.020
 Why?
Hydrogen Peroxide
1
2007
308
0.020
 Why?
Recurrence
1
2008
993
0.010
 Why?
Urban Population
1
2008
440
0.010
 Why?
Graft Rejection
1
2008
557
0.010
 Why?
Animals, Newborn
1
2007
801
0.010
 Why?
Self Efficacy
1
2008
371
0.010
 Why?
Recombinant Fusion Proteins
1
2006
634
0.010
 Why?
Atrial Fibrillation
1
2008
374
0.010
 Why?
Myocardial Infarction
1
2011
1013
0.010
 Why?
Program Evaluation
1
2007
872
0.010
 Why?
Age Factors
1
2009
3100
0.010
 Why?
Curriculum
1
2007
909
0.010
 Why?
Apoptosis
1
2008
2425
0.010
 Why?
Cells, Cultured
1
2007
4006
0.010
 Why?
Cytokines
1
2007
1984
0.010
 Why?
Health Knowledge, Attitudes, Practice
1
2007
1272
0.010
 Why?
Parents
1
2007
1303
0.010
 Why?
Neurons
1
2007
1445
0.010
 Why?
Child
1
2007
20636
0.000
 Why?
Gonzales's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (305) concept(s)
_
Co-Authors Expand Description
See all (12) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)